Management of acute asthma exacerbations

Area of Science:

• Pediatric Pulmonology
• Emergency Medicine
• Critical Care

Background:

• Asthma is a leading chronic condition in children and a primary cause of hospital admissions.
• Acute asthma exacerbations represent a significant healthcare burden despite recent trends in prevalence.
• Evidence supporting specific pharmacologic agents for acute pediatric asthma is limited.

Purpose of the Study:

• To review current management guidelines for acute asthma exacerbations in children.
• To focus on emergency department, inpatient, and intensive care unit (ICU) settings.
• To highlight strategies for improving outcomes and reducing costs.

Main Methods:

• Review of current clinical practice guidelines.
• Analysis of recent epidemiological and healthcare expenditure data.
• Synthesis of quality improvement studies.

Main Results:

• Childhood asthma prevalence shows varied trends across demographic groups.
• Acute asthma exacerbations contribute substantially to healthcare costs.
• Quality improvement science has demonstrated potential for cost reduction and outcome enhancement.

Conclusions:

• Management principles include reversing bronchospasm, correcting hypoxia, and preventing relapse.
• Use of second- and third-tier agents is generally restricted to the ICU.
• Reducing treatment variability is crucial for lowering costs and improving pediatric asthma care outcomes.